Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
NNMT-IN-3
Cat. No.:
OB0425LY-180
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
NNMT-IN-3 is a selective NNMT inhibitor that affects metabolic and neurobiological processes.
Synonyms:
3031493-74-7; NMT-IN-3; NMT-IN3
CAS No.:
3031493-74-7
Formula:
C34H34ClN7O
Formula Weight:
592.13
Specification
Target:
Amine N-methyltransferase
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
NNMT-IN-3 can be used to screen for biomarkers associated with cancer, metabolic syndrome and other neurological diseases.
